Skip to content
Disclosery

Endurant Capital Management LP

Follow

13F filer, CIK 1633055, San Mateo, CA

Endurant Capital Management LP reported $246,253,014 across 55 holdings for the quarter ended 2022-12-31, in a 13F-HR filed 2023-02-14. Its ten largest share positions make up 67.39% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001633055-23-000002

Period
2022-12-31
Reported value
$246M
Holdings
55
Top 10 weight
67.39%
New
29
Sold out
23

Largest buys vs the previous quarter

SecurityShares changeApprox. value
MRKnew+126,003$14M
CNCnew+168,363$13.8M
SBRAnew+436,524$5.43M
CIadded+15,579$5.16M
ELVadded+9,675$4.96M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
HUMexited-32,729-$15.9M
TAKexited-1,102,280-$14.3M
QIAGEN NVreduced-263,179-$13.1M
LLYexited-38,311-$12.4M
BAXreduced-234,085-$11.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2022

Share positions as resolved from 13F-HR 0001633055-23-000002, largest first. % of portfolio is the value over $246,253,014, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
INVACARE CORPINVACARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 56,727,000 shares; 2022Q3: 56,727,000 shares; 2022Q4: 56,727,000 shares 56,727,000$48.7M19.78%0
LABORATORY CRP OF AMER HLDGSLABORATORY CRP OF AMER HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 34,718 shares; 2022Q3: 97,245 shares; 2022Q4: 90,924 shares 90,924$21.4M8.69%-6,321
CITHE CIGNA GROUPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 40,372 shares; 2022Q3: 34,099 shares; 2022Q4: 49,678 shares 49,678$16.5M6.68%+15,579Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 126,003 shares 126,003$14M5.68%newTimeline
CNCCENTENE CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 68,305 shares; 2022Q3: not reported; 2022Q4: 168,363 shares 168,363$13.8M5.61%newTimeline
ELVELEVANCE HEALTH INC FORMERLYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 16,402 shares; 2022Q4: 26,077 shares 26,077$13.4M5.43%+9,675Timeline
ICLRICON PUB LTD COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 49,718 shares; 2022Q3: 66,437 shares; 2022Q4: 58,896 shares 58,896$11.4M4.65%-7,541Timeline
AZNASTRAZENECA PLC-SPONS ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 101,048 shares; 2022Q4: 141,420 shares 141,420$9.59M3.89%+40,372Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 25,975 shares; 2022Q3: 145,374 shares; 2022Q4: 84,357 shares 84,357$8.73M3.55%-61,017Timeline
INVACARE CORPINVACARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 10,097,000 shares; 2022Q3: 10,097,000 shares; 2022Q4: 10,097,000 shares 10,097,000$8.46M3.43%0
SBRASABRA HEALTH CARE REIT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 436,524 shares 436,524$5.43M2.2%newTimeline
ELUTELUTIA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 1,133,183 shares; 2022Q3: 1,139,932 shares; 2022Q4: 1,259,544 shares 1,259,544$5.35M2.17%+119,612Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 142,071 shares; 2022Q3: 107,713 shares; 2022Q4: 243,122 shares 243,122$4.86M1.97%+135,409Timeline
ALBIREO PHARMA INCALBIREO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 37,835 shares; 2022Q3: 172,621 shares; 2022Q4: 217,209 shares 217,209$4.69M1.91%+44,588
EHCENCOMPASS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 82,929 shares; 2022Q4: 78,144 shares 78,144$4.67M1.9%-4,785Timeline
SELECTA BIOSCIENCES INCSELECTA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 4,611,635 shares; 2022Q3: 3,938,409 shares; 2022Q4: 3,777,618 shares 3,777,618$4.27M1.73%-160,791
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 433,035 shares 433,035$4.07M1.65%newTimeline
CORCENCORA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 11,515 shares; 2022Q3: not reported; 2022Q4: 21,034 shares 21,034$3.49M1.42%newTimeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 21,664 shares 21,664$3.25M1.32%newTimeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 760,228 shares; 2022Q3: 1,064,295 shares; 2022Q4: 1,063,953 shares 1,063,953$2.99M1.21%-342Timeline
ADAPYADAPTIMMUNE THERAPEUTICS PLC SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 1,824,065 shares; 2022Q3: 1,788,517 shares; 2022Q4: 1,733,236 shares 1,733,236$2.53M1.03%-55,281Timeline
ZTSZOETIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 41,100 shares; 2022Q3: 44,286 shares; 2022Q4: 16,728 shares 16,728$2.45M1%-27,558Timeline
SUTRO BIOPHARMA INCSUTRO BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 357,465 shares; 2022Q3: 266,679 shares; 2022Q4: 281,895 shares 281,895$2.28M0.92%+15,216
QIAGEN NVQIAGEN NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 398,221 shares; 2022Q3: 303,928 shares; 2022Q4: 40,749 shares 40,749$2.03M0.83%-263,179
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 47,442 shares; 2022Q3: 70,535 shares; 2022Q4: 40,452 shares 40,452$1.97M0.8%-30,083Timeline
BDXBECTON DICKINSON & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 34,282 shares; 2022Q4: 6,761 shares 6,761$1.72M0.7%-27,521Timeline
BIOBIO RAD LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 16,028 shares; 2022Q3: 6,984 shares; 2022Q4: 3,893 shares 3,893$1.64M0.66%-3,091Timeline
CATALENT INC USD 0.01CATALENT INC USD 0.01Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 140,077 shares; 2022Q4: 35,265 shares 35,265$1.59M0.64%-104,812
SILK ROAD MEDICAL INCSILK ROAD MEDICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 29,967 shares 29,967$1.58M0.64%new
HCAHCA HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 6,595 shares 6,595$1.58M0.64%newTimeline
DOCHEALTHPEAK PROPERTIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 59,578 shares 59,578$1.49M0.61%newTimeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 135,994 shares 135,994$1.38M0.56%newTimeline
CRLCHARLES RIV LABS INTL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 6,258 shares 6,258$1.36M0.55%newTimeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 28,187 shares 28,187$1.14M0.46%newTimeline
BCABBIOATLA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 136,382 shares 136,382$1.13M0.46%newTimeline
TXG10X GENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 30,357 shares 30,357$1.11M0.45%newTimeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 4,596 shares 4,596$1.09M0.44%newTimeline
GRITSTONE BIO INCGRITSTONE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 282,935 shares 282,935$976K0.4%new
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 1,589 shares 1,589$875K0.36%newTimeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 15,246 shares; 2022Q3: not reported; 2022Q4: 11,264 shares 11,264$869K0.35%newTimeline
XRAYDENTSPLY SIRONA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 22,088 shares 22,088$703K0.29%newTimeline
PTCTPTC THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 17,886 shares 17,886$683K0.28%newTimeline
NTLAINTELLIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 16,401 shares 16,401$572K0.23%newTimeline
BAXBAXTER INTL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 89,863 shares; 2022Q3: 245,093 shares; 2022Q4: 11,008 shares 11,008$561K0.23%-234,085Timeline
IGM BIOSCIENCES INCIGM BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 30,320 shares 30,320$516K0.21%new
ATNMACTINIUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 45,612 shares 45,612$486K0.2%newTimeline
89BIO INC89BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 36,784 shares 36,784$468K0.19%new
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 70,655 shares 70,655$451K0.18%newTimeline
ITEOS THERAPEUTICS INCITEOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 21,041 shares 21,041$411K0.17%new
INHIBRX INCINHIBRX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 13,485 shares 13,485$332K0.13%new
MRVIMARAVAI LIFESCIENCES HLDGS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 23,015 shares; 2022Q3: 22,709 shares; 2022Q4: 21,458 shares 21,458$307K0.12%-1,251Timeline
BIODESIX INCBIODESIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 130,753 shares; 2022Q3: 130,136 shares; 2022Q4: 124,430 shares 124,430$286K0.12%-5,706
BMEABIOMEA FUSION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 33,881 shares 33,881$286K0.12%newTimeline
OYSTER POINT PHARMA INCOYSTER POINT PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 19,927 shares 19,927$223K0.09%new
ATHENEX INCATHENEX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 526,651 shares; 2022Q4: 902,236 shares 902,236$133K0.05%+375,585

Sold out in Q4 2022

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
HUMHUMANA INC32,729$15.9Mshares
TAKTAKEDA PHARMACEUTICAL CO LTD1,102,280$14.3Mshares
LLYELI LILLY & CO38,311$12.4Mshares
BMYBRISTOL-MYERS SQUIBB CO158,721$11.3Mshares
OHIOMEGA HEALTHCARE INVS INC313,762$9.25Mshares
MCKMCKESSON CORP16,168$5.5Mshares
VTRVENTAS INC85,683$3.44Mshares
MMSIMERIT MED SYS INC51,218$2.89Mshares
RCUSARCUS BIOSCIENCES INC97,327$2.55Mshares
LKFTLAKEFRONT BIOTHERAPEUTICS NV50,822$2.17Mshares
CANO HEALTH INCCANO HEALTH INC210,915$1.83Mshares
VCYTVERACYTE INC108,751$1.8Mshares
AVTRAVANTOR INC75,948$1.49Mshares
TEVATEVA PHARMACEUTICAL INDS LTD179,226$1.45Mshares
OPCHOPTION CARE HEALTH INC43,457$1.37Mshares
ACHACCENDRA HEALTH INC55,914$1.35Mshares
PCVXVAXCYTE INC52,309$1.25Mshares
REATA PHARMACEUTICALS INCREATA PHARMACEUTICALS INC24,352$612Kshares
ABOSACUMEN PHARMACEUTICALS INC55,328$555Kshares
MIRATI THERAPEUTICS INCMIRATI THERAPEUTICS INC7,915$553Kshares
RLMDRELMADA THERAPEUTICS INC14,145$524Kshares
CYTKCYTOKINETICS INC9,211$446Kshares
MORPHOSYS AGMORPHOSYS AG68,290$344Kshares

How Q4 2022 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001633055-23-000002 base2023-02-14acceptance time not in the bulk data set